| Black Rock Coffee Bar, Inc. Reports First Quarter 2026 Results |
Globe Newswire |
05/12 |
16:06 |
| Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs |
Globe Newswire |
05/12 |
16:05 |
| Red Cat Announces Proposed Public Offering of Common Stock |
Globe Newswire |
05/12 |
16:05 |
| Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update |
Globe Newswire |
05/12 |
16:05 |
| Pharvaris Reports First Quarter 2026 Financial Results and Provides Business Update |
Globe Newswire |
05/12 |
16:05 |
| Saucony® Appoints Wendy Kula as Chief Marketing Officer |
Globe Newswire |
05/12 |
16:03 |
| CSX Corporation Declares Quarterly Dividend |
Globe Newswire |
05/12 |
16:02 |
| Kyverna Therapeutics Announces Initiation of Rolling SPS BLA Submission and Reports First Quarter 2026 Financial Results |
Globe Newswire |
05/12 |
16:02 |
| Kura Oncology Reports First Quarter 2026 Financial Results |
Globe Newswire |
05/12 |
16:02 |
| Maze Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights |
Globe Newswire |
05/12 |
16:01 |
| Verrica Pharmaceuticals Reports First Quarter 2026 Financial Results |
Globe Newswire |
05/12 |
16:01 |
| OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance |
Globe Newswire |
05/12 |
16:01 |
| BIO-key Shares Expected to Temporarily Move to OTC™ Markets Tomorrow, Wednesday May 13th Following Nasdaq Suspension After Today’s Market Close; BIO-key is Seeking to Restore Nasdaq Listing Expeditiously |
Globe Newswire |
05/12 |
16:01 |
| Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees |
Globe Newswire |
05/12 |
16:01 |
| IZEA Reports Q1 2026 Revenue of $6.6 Million, Strengthens Enterprise Client Base, Launches AI-Powered ZED Platform |
Globe Newswire |
05/12 |
16:01 |
| Cytokinetics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference |
Globe Newswire |
05/12 |
16:00 |
| Molecular Partners Reports Financial Results and Highlights for Q1 2026, with Clinical Studies Initiated on MP0712 and MP0317 |
Globe Newswire |
05/12 |
16:00 |
| Winners, Inc. Announces 300-1 Reverse Stock Split to Position for Strategic Growth and Future Uplisting Strategy |
Globe Newswire |
05/12 |
16:00 |
| Pomerantz Law Firm Announces the Filing of a Class Action Against Babcock & Wilcox Enterprises, Inc.and Certain Officers – BW |
Globe Newswire |
05/12 |
15:59 |
| INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vital Farms, Inc. Of Class Action Lawsuit and Upcoming Deadlines – VITL |
Globe Newswire |
05/12 |
15:59 |
| Javatide Gets Reviewed: Complete Formula Evaluation of Ingredient Claims and Side Effects Risk |
Globe Newswire |
05/12 |
15:58 |
| INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Power Solutions International, Inc. of Class Action Lawsuit and Upcoming Deadlines – PSIX |
Globe Newswire |
05/12 |
15:58 |
| INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Alight, Inc. of Class Action Lawsuit and Upcoming Deadlines – ALIT |
Globe Newswire |
05/12 |
15:56 |
| Pomerantz Law Firm Announces the Filing of a Class Action Against Gemini Space Station, Inc. and Certain Officers – GEMI |
Globe Newswire |
05/12 |
15:53 |
| Correction: South Jersey Industries, Inc. Commences Tender Offer to Purchase for Cash Any and All of the Outstanding 2018 Series A 3.70% Remarketable Junior Subordinated Notes due 2031 |
Globe Newswire |
05/12 |
15:50 |
